GEPD is a joint-venture company between Egypt’s National Service Projects Organization (NSPO) and Grifols, an innovative global leader in the production of plasma-derived medicines that for more than 110 years has contributed to improving people’s health and quality of life.

Earlier this year we began taking donations at our flagship 6th of October donor center, located in Cairo’s Western Giza district. It’s the cornerstone of an expansive integrated plasma ecosystem that over the next few years will see the opening of 20 donation centers, facilities to test and manufacture plasma into medicines, and warehousing operations.

It will be the first plasma infrastructure of its kind in Egypt, or anywhere else in the broader African and Middle East regions. Ensuring the country is self-sufficient in plasma-protein therapies will reinforce the nation’s healthcare leadership.

Expertise, technology, and resources from both organizations are contributing to the success of the initiative.

Contribute to the National Sustainable Development Strategy (SDS) and Egypt Vision 2030 by:

 

  • Achieving self-sufficiency in plasma derivatives in the Arab Republic of Egypt, in addition to supporting the Egyptian healthcare system and positively impacting the health of Egyptian patients.
  • Developing and supporting Egyptian expertise in plasma and plasma-derived medicines manufactured according to the highest international quality and safety standards.
  • Achieving leadership in manufacturing, producing and distributing plasma-derived medicines in the Middle East and Africa.
  • Localizing the industry through technology transfer.
  • Periodic health screening of the Egyptian population.
Message from CEO

Message from Dr.Magdy Amin, Chief Executive Officer Grifols Egypt for Plasma Derivatives.

Read more

Partnership

GEPD is a joint-venture (JV) company between Grifols and the Government of Egypt, through the National Service Projects Organization (NSPO).

Read more